Biggest News Aggregation in the World
📰 Beigene News

Page 16 - Beigene News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Beigene. Real-time updates on events, politics, business and more.

BeiGene, Ltd. (NASDAQ:BGNE) CFO Julia Aijun Wang Sells 161 Shares

BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) CFO Julia Aijun Wang sold 161 shares of BeiGene stock in a transaction dated Friday, June 17th. The stock was sold at an average price of $136.64, for a total value of $21,999.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is […]
United States Julia Aijun Wang Morgan Stanley Securities Exchange Commission Segantii Capital Management Ltd Beigene Ltd

BeiGene cancer drug receives further international approval

Chinese biotech enterprise BeiGene announced on Monday that its cancer treatment Brukinsa (zanubrutinib) has been approved by authorities in Kuwait, Bahrain and Qatar for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy.This development means the drug has received more than 20 approvals covering 50 countries and regions, including the United States, China, the European Union, Great Britain, Canada, and Australia. Currently, more than 40 addit...
United States United Kingdom Saudi Arabia United Arab Emirates Great Britain European Union

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

BeiGene Announces BRUKINSA (zanubrutinib) Is Approved in 50 Markets

13.06.2022 - BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide today announced that its BTK ... Seite 1
Saudi Arabia Ministry Of Health United Arab Emirates Abdul Aziz Hamadah National Health Regulatory Authority Head Of Hematology Department

Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Quarterly Sales of $312.21 Million

Equities analysts expect that BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) will report $312.21 million in sales for the current quarter, Zacks reports. Two analysts have issued estimates for BeiGene’s earnings, with the lowest sales estimate coming in at $307.52 million and the highest estimate coming in at $316.90 million. BeiGene posted sales of $149.99 million […]
United States Xiaobin Wu Morgan Stanley Beigene Company Profile Get Rating Zacks Investment Research Deutsche Bank Aktiengesellschaft

Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Announce Earnings of -$4.38 Per Share

Wall Street brokerages predict that BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) will post ($4.38) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for BeiGene’s earnings, with the lowest EPS estimate coming in at ($4.45) and the highest estimate coming in at ($4.30). BeiGene reported […]
United States Xiaobin Wu American Century Companies Inc Morgan Stanley Geode Capital Management Securities Exchange Commission

BeiGene, Ltd. (NASDAQ:BGNE) Receives Average Rating of "Buy" from Brokerages

Shares of BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) have been given an average recommendation of “Buy” by the eight ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating on the company. The […]
United States Xiaobin Wu Shaughnessy Asset Management Morgan Stanley Assetmark Inc Securities Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science